The global race is on to develop a vaccine against COVID-19. While it usually takes many years to develop and widely distribute vaccines, scientists around the world are now trying to get one ready within the next year — an unprecedented time frame.
The race has generated fierce competition among countries, as everyone wants to develop a vaccine on their home turf first, not only for prestige, but also to get their citizens at the front of the line for the shots when they are available. Still, while the scientific world is now rife with geopolitical rivalries over the COVID-19 vaccine, there's also a lot of international collaboration going on behind the scenes. Here's a look at the vaccines currently in Phase II of the clinical trial process, meaning they are being tested on hundreds of people of various age groups to determine their effectiveness and safety. If they pass this stage they move to wider testing in Phase III, the final step before approval.
More For You
Tune in on Saturday, February 14th at 12pm ET/6pm CET for the live premiere of our Global Stage from the 2026 Munich Security Conference, where our panel of experts takes aim at the latest global security challenges.
Most Popular
Think you know what's going on around the world? Here's your chance to prove it.
At the Munich Security Conference, the mood is clear: Europe no longer assumes the United States will lead. In this Quick Take, Ian Bremmer reports from Munich, where this year’s theme, “Under Destruction,” reflects growing anxiety that the US itself is destabilizing the transatlantic alliance it once anchored.
Every year, the Munich Security Conference, the world’s leading forum on international security, releases data that sheds light on how citizens view global risks.
